Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOGMES: PLD in Elderly Metastatic Breast Cancer
NCT00960336Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Mar 2008
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxorubicin in breast cancer, sponsored by ARCAGY. Primary endpoint: Objective Response Rate. Started Mar 2008; status: completed.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00960336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960336.